Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA

被引:9
|
作者
Jiang, Longying [1 ]
Liu, Xueke [1 ]
Liang, Xujun [1 ]
Dai, Shuyan [1 ]
Wei, Hudie [1 ]
Guo, Ming [1 ]
Chen, Zhuchu [1 ]
Xiao, Desheng [1 ]
Chen, Yongheng [1 ]
机构
[1] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriat Disorders, Dept Pathol,NHC Key Lab Canc Proteom,State Local J, Changsha, Hunan, Peoples R China
来源
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL | 2023年 / 21卷
基金
中国国家自然科学基金; 美国国家科学基金会;
关键词
Farnesoid X receptor; Retinoid X receptor; Heterodimer; Inverted repeat DNA; Crystal structure; TRANSCRIPTION FACTORS; NUCLEAR RECEPTORS; BINDING; FXR; RXR; LIVER; ARCHITECTURES; ELEMENTS; PACKAGE; COMPLEX;
D O I
10.1016/j.csbj.2023.05.026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Farnesoid X receptor (FXR) is a ligand-activated transcription factor known as bile acid receptor (BAR). FXR plays critical roles in various biological processes, including metabolism, immune inflammation, liver re-generation and liver carcinogenesis. FXR forms a heterodimer with the retinoid X receptor (RXR) and binds to diverse FXR response elements (FXREs) to exert its various biological functions. However, the mechanism by which the FXR/RXR heterodimer binds the DNA elements remains unclear. In this study, we aimed to use structural, biochemical and bioinformatics analyses to study the mechanism of FXR binding to the typical FXRE, such as the IR1 site, and the heterodimer interactions in the FXR-DBD/RXR-DBD complex. Further biochemical assays showed that RAR, THR and NR4A2 do not form heterodimers with RXR when bound to the IR1 sites, which indicates that IR1 may be a unique binding site for the FXR/RXR heterodimer. Our studies may provide a further understanding of the dimerization specificity of nuclear receptors.& COPY; 2023 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology. This is an open access article under the CC BY-NC-ND license (http://creative-commons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:3149 / 3157
页数:9
相关论文
共 50 条
  • [31] Monitoring of the retinoic acid receptor-retinoid X receptor dimerization upon DNA binding by native mass spectrometry
    Nha-Thi Nguyen-Huynh
    Osz, Judit
    Peluso-Iltis, Carole
    Rochel, Natacha
    Potier, Noelle
    Leize-Wagner, Emmanuelle
    BIOPHYSICAL CHEMISTRY, 2016, 210 : 2 - 8
  • [32] Farnesoid X receptor activation inhibits pancreatic carcinogenesis
    Xu, Zhen
    Huang, Zhenhua
    Zhang, Yifan
    Sun, Haitao
    Hinz, Ulf
    Heger, Ulrike
    Loos, Martin
    Gonzalez, Frank J.
    Hackert, Thilo
    Bergmann, Frank
    Fortunato, Franco
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2023, 1869 (07):
  • [33] Bile Acids and Farnesoid X Receptor in Renal Pathophysiology
    Yang, Jiufang
    Pontoglio, Marco
    Terzi, Fabiola
    NEPHRON, 2024, 148 (09) : 618 - 630
  • [34] The role of the farnesoid X receptor in diabetes and its complications
    Zhang, Shengnan
    Zhang, Dandan
    Xu, Kui
    Huang, Xingqiong
    Chen, Qingjie
    Chen, Mi
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, : 2725 - 2736
  • [35] Farnesoid X receptor agonists for primary biliary cirrhosis
    Lindor, Keith D.
    CURRENT OPINION IN GASTROENTEROLOGY, 2011, 27 (03) : 285 - 288
  • [36] Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
    Zhou, Mengjiao
    Wang, Danfeng
    Li, Xiang
    Cao, Ying
    Yi, Chengxue
    Wiredu Ocansey, Dickson Kofi
    Zhou, Yuling
    Mao, Fei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis
    Jiao, Yang
    Lu, Yan
    Li, Xiao-ying
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (01) : 44 - 50
  • [38] On the Evolution of Bile Salts and the Farnesoid X Receptor in Vertebrates
    Frisch, Kim
    Alstrup, Aage Kristian Olsen
    PHYSIOLOGICAL AND BIOCHEMICAL ZOOLOGY, 2018, 91 (02): : 797 - 813
  • [39] Patented Farnesoid X receptor modulators: a review (2019-present)
    Gioiello, Antimo
    Rosatelli, Emiliano
    Cerra, Bruno
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2024, 34 (07) : 547 - 564
  • [40] Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition
    Renga, Barbara
    Mencarelli, Andrea
    D'Amore, Claudio
    Cipriani, Sabrina
    Baldelli, Franco
    Zampella, Angela
    Distrutti, Eleonora
    Fiorucci, Stefano
    FASEB JOURNAL, 2012, 26 (07) : 3021 - 3031